2025 · 3rd Quarter (July 1 - Sep 30)

SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)

Filed by TARPLIN, DOWNS & YOUNG, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 16, 2025
Income: $60,000.00
Expenses: Not reported
Registrant: TARPLIN, DOWNS & YOUNG, LLC
Client: SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)
Filing UUID: f7f1e030-7d11-465a-b1c9-288a711c70e5
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

IRA, transparency, vaccines, coverage and access

HCR · Health Issues

IRA, supply chain integrity, drug pricing in federal programs, orphan drugs, newborn screening, expanded access, transparency, drug shortages, drug pricing, insulin, diabetes screening, COPD

BUD · Budget/Appropriations

federal budget issues

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.